On (i) Its 100% acquisition of Fertin Pharma (including its wholly-owned Indian subsidiaries) which involved extensive due diligence and review of intellectual property assets, reviewing intra—group licensing and employment agreements (ii) Advising on Indian data privacy practices and compliance